AFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M

Dow Jones

01/14

    AFC-HD AMS Life Science Co. Ltd. (2927.TO) 
    Japan 
    1st Quarter Ended November 30 
GROUP                2025                 2024 
Revenue              Y8.55 bln       Y8.19 bln 
Operating Profit     Y771.00 mln   Y650.00 mln 
Pretax Profit        Y739.00 mln   Y704.00 mln 
Net Profit           Y522.00 mln   Y460.00 mln 
Per share 
  Earnings           Y36.70             Y32.70 
  Diluted Earnings   N/A                Y32.69 
 
    Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: 
GROUP              1st Half To 
                      Feb 2026 
Revenue             Y16.73 bln 
Operating Profit     Y1.30 bln 
Pretax Profit        Y1.33 bln 
Net Profit         Y883.00 mln 
Per share 
  Earnings              Y59.11 
 
    Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

January 14, 2026 01:36 ET (06:36 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2603466238"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603466238\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603466238?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 14:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603466238","market":"other","top_or_hot":-1,"title":"AFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. (2927.TO) \n    Japan \n    1st Quarter Ended November 30 \nGROUP                2025                 2024 \nRevenue              Y8.55 bln       Y8.19 bln \nOperating Profit     Y771.00 mln   Y650.00 mln \nPretax Profit        Y739.00 mln   Y704.00 mln \nNet Profit           Y522.00 mln   Y460.00 mln \nPer share \n  Earnings           Y36.70             Y32.70 \n  Diluted Earnings   N/A                Y32.69 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: \nGROUP              1st Half To \n                      Feb 2026 \nRevenue             Y16.73 bln \nOperating Profit     Y1.30 bln \nPretax Profit        Y1.33 bln \nNet Profit         Y883.00 mln \nPer share \n  Earnings              Y59.11 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 14, 2026 01:36 ET (06:36 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-14 14:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. (2927.TO) \n    Japan \n    1st Quarter Ended November 30 \nGROUP                2025                 2024 \nRevenue              Y8.55 bln       Y8.19 bln \nOperating Profit     Y771.00 mln   Y650.00 mln \nPretax Profit        Y739.00 mln   Y704.00 mln \nNet Profit           Y522.00 mln   Y460.00 mln \nPer share \n  Earnings           Y36.70             Y32.70 \n  Diluted Earnings   N/A                Y32.69 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: \nGROUP              1st Half To \n                      Feb 2026 \nRevenue             Y16.73 bln \nOperating Profit     Y1.30 bln \nPretax Profit        Y1.33 bln \nNet Profit         Y883.00 mln \nPer share \n  Earnings              Y59.11 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 14, 2026 01:36 ET (06:36 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1035775433.USD","symbol_name":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2603466238","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603466238","pubTimestamp":1768372560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK6062":"电子制造服务","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4581":"高盛持仓","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","HD":"家得宝","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0238689110.USD":"贝莱德环球动力股票基金","BK4566":"资本集团","BK4083":"家庭装潢零售","AMS":"American Shared Hospital Services","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD)  INC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0823411888.USD":"法巴消费创新基金 Cap","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","BK4504":"桥水持仓","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","BK4588":"碎股","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4550":"红杉资本持仓","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","BK6515":"技术设备股","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU1236620750.USD":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (USD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","M11.SI":"综合制造科技","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","BK4196":"保健护理服务","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC"},"translate_title":"AFC HD AMS生命科学第一季度净值Y522.00M Vs净值Y460.00M","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HD":1.5,"AMS":1.5,"M11.SI":1.5},"content_text":"AFC-HD AMS Life Science Co. Ltd. (2927.TO) \n    Japan \n    1st Quarter Ended November 30 \nGROUP                2025                 2024 \nRevenue              Y8.55 bln       Y8.19 bln \nOperating Profit     Y771.00 mln   Y650.00 mln \nPretax Profit        Y739.00 mln   Y704.00 mln \nNet Profit           Y522.00 mln   Y460.00 mln \nPer share \n  Earnings           Y36.70             Y32.70 \n  Diluted Earnings   N/A                Y32.69 \n \n    Results are based on Japanese accounting standards. \n\n\n  (END) Dow Jones Newswires\n\n\n\n    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: \nGROUP              1st Half To \n                      Feb 2026 \nRevenue             Y16.73 bln \nOperating Profit     Y1.30 bln \nPretax Profit        Y1.33 bln \nNet Profit         Y883.00 mln \nPer share \n  Earnings              Y59.11 \n \n    Results are based on Japanese accounting standards. \n\n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  January 14, 2026 01:36 ET (06:36 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}